These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 19892916)
41. Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland. Suh JM; Song JH; Kim DW; Kim H; Chung HK; Hwang JH; Kim JM; Hwang ES; Chung J; Han JH; Cho BY; Ro HK; Shong M J Biol Chem; 2003 Jun; 278(24):21960-71. PubMed ID: 12668683 [TBL] [Abstract][Full Text] [Related]
42. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. Han S; Khuri FR; Roman J Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245 [TBL] [Abstract][Full Text] [Related]
43. Zoledronic acid induces S-phase arrest via a DNA damage response in normal human oral keratinocytes. Ohnuki H; Izumi K; Terada M; Saito T; Kato H; Suzuki A; Kawano Y; Nozawa-Inoue K; Takagi R; Maeda T Arch Oral Biol; 2012 Jul; 57(7):906-17. PubMed ID: 22172403 [TBL] [Abstract][Full Text] [Related]
44. Effects of rapamycin on cell proliferation and phosphorylation of mTOR and p70(S6K) in HepG2 and HepG2 cells overexpressing constitutively active Akt/PKB. Varma S; Khandelwal RL Biochim Biophys Acta; 2007 Jan; 1770(1):71-8. PubMed ID: 16952420 [TBL] [Abstract][Full Text] [Related]
45. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition. Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559 [TBL] [Abstract][Full Text] [Related]
46. Rapamycin, the mTOR kinase inhibitor, sensitizes acute myeloid leukemia cells, HL-60 cells, to the cytotoxic effect of arabinozide cytarabine. Janus A; Linke A; Cebula B; Robak T; Smolewski P Anticancer Drugs; 2009 Sep; 20(8):693-701. PubMed ID: 19584709 [TBL] [Abstract][Full Text] [Related]
54. Strain-induced vascular endothelial cell proliferation requires PI3K-dependent mTOR-4E-BP1 signal pathway. Li W; Sumpio BE Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1591-7. PubMed ID: 15591103 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis. Huber S; Bruns CJ; Schmid G; Hermann PC; Conrad C; Niess H; Huss R; Graeb C; Jauch KW; Heeschen C; Guba M Kidney Int; 2007 Apr; 71(8):771-7. PubMed ID: 17299523 [TBL] [Abstract][Full Text] [Related]
56. The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism. Erbay E; Chen J J Biol Chem; 2001 Sep; 276(39):36079-82. PubMed ID: 11500483 [TBL] [Abstract][Full Text] [Related]
57. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity. deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641 [TBL] [Abstract][Full Text] [Related]
58. Rapamycin selectively inhibits expression of an inducible keratin (K6a) in human keratinocytes and improves symptoms in pachyonychia congenita patients. Hickerson RP; Leake D; Pho LN; Leachman SA; Kaspar RL J Dermatol Sci; 2009 Nov; 56(2):82-8. PubMed ID: 19699613 [TBL] [Abstract][Full Text] [Related]
59. Roles of phosphatidylinositol 3'-kinase and mammalian target of rapamycin/p70 ribosomal protein S6 kinase in K-Ras-mediated transformation of intestinal epithelial cells. Shao J; Evers BM; Sheng H Cancer Res; 2004 Jan; 64(1):229-35. PubMed ID: 14729629 [TBL] [Abstract][Full Text] [Related]
60. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]